Skip to main content

Ferroportin Disease

Ferroportin Disease  


DISEASE OVERVIEW

Ferroportin disease, also known as hemochromatosis type 4, is a rare genetic disorder characterized by the abnormal accumulation of iron in the body. Ferroportin disease is caused by changes (variants or mutations) of the SLC40A1 gene. The specific symptoms associated with ferroportin disease can vary greatly from one person to another. Some individuals may only have elevated levels of ferritin, a protein that binds to iron and is used as an indicator of the body’s iron stores in the blood plasma. Other individuals may develop symptoms similar to classic HFE-related hemochromatosis.

Ferroportin disease is classified as an iron overload disorder, a group of disorders characterized by the abnormal accumulation of iron in the body. It is a separate, distinct disorder from classic hereditary hemochromatosis. Ferroportin disease is caused by variants in a different gene and is inherited in a different manner from other forms of hemochromatosis.

SIGNS & SYMPTOMS

The symptoms of ferroportin disease vary greatly from one person to another. Researchers believe that different variants in the SLC40A1 gene are associated with different symptoms. Generally, ferroportin disease is separated into two main forms.

Most individuals with ferroportin disease develop a mild form of the disorder. These individuals have elevated levels of ferritin in the blood plasma (hyperferritinemia) and low levels of saturated transferrin (the protein that carries iron in the blood). As affected individuals age, mild liver damage (hepatic fibrosis) and joint symptoms may occur.

Other individuals develop a rarer form of ferroportin disease that resembles the more common classic form of hemochromatosis (hemochromatosis type 1 or HFE-related). The transferrin saturation is significantly elevated in this form. Symptoms associated with this form include joint pain, abnormalities in the heart’s rhythm or heartbeat pattern (arrhythmias) and diabetes. Liver damage is more prevalent in this form of ferroportin disease and can progress to cause advanced scarring (cirrhosis) of the liver.

CAUSES

Ferroportin disease is caused by variants in the SLC40A1 gene. The SLC40A1 gene contains instructions for creating ferroportin, a specialized protein that is crucial to the proper export of iron from cells. Ferroportin also plays a role in the proper breakdown (metabolism) of iron. Iron is a critical mineral that is found in all cells of the body and is essential for the body to function and grow properly. Iron is found in many types of food including red meat, poultry, eggs and vegetables. Iron levels must remain in a specific range within the body, otherwise they can cause anemia (due to low iron levels) or damage affected organs (due to high iron levels).

Variants in the SLC40A1 gene result in low levels of functional ferroportin. The lack of functional ferroportin ultimately results in the abnormal accumulation of iron in the cells and tissues of the body. Different variants of the SLC40A1 gene affect the ferroportin protein in different ways, altering the export and metabolism of iron accordingly. Researchers believe that the different ways in which SLC40A1 variants affect ferroportin account for the two different forms of the disorder.

Ferroportin disease is inherited as an autosomal dominant genetic condition. Dominant genetic disorders occur when only a single copy of an abnormal gene is necessary for the appearance of the disease. The abnormal gene can be inherited from either parent or can be the result of a new gene change in the affected individual. The risk of passing the abnormal gene from affected parent to offspring is 50 percent for each pregnancy. The risk is the same for males and females.

DISORDERS WITH SIMILAR SYMPTOMS

Symptoms of the following disorders can be similar to those of ferroportin disease. Comparisons may be useful for a differential diagnosis.

Primary disorders of iron overload are a group of rare disorders characterized by iron accumulation in the body. This group includes hemochromatosis, atransferrinemia, acaeruloplasminemia, neonatal hemochromatosis and African iron overload. Hemochromatosis has been separated into four distinct disorders – hereditary (classic) hemochromatosis, also known as HFE-related hemochromatosis; hemochromatosis type 2 (juvenile hemochromatosis); hemochromatosis type 3, also known as TFR2-related hemochromatosis and hemochromatosis type 4, also known as ferroportin disease. Types 2-4 have been more recently bracketed as ‘non-HFE’ hemochromatosis. The specific symptoms related to these disorders can vary depending upon the location and extent of iron accumulation. Common symptoms include fatigue, abdominal pain, lack of sex drive, joint pain and heart abnormalities. If left untreated, iron can build up in various organs in the body causing serious, life-threatening complications. (For more information on these disorders, choose the specific disorder name as your search term in the Rare Disease Database.)

DIAGNOSIS

A diagnosis of ferroportin disease is made based upon identification of characteristic symptoms, a detailed patient history, a thorough clinical evaluation and a variety of specialized tests. A family history with affected individuals in successive generations is highly suggestive (autosomal dominant inheritance). Blood tests can reveal certain findings associated with ferroportin disease including high levels of ferritin in the blood and, in the milder form of the disease, low or normal saturation of transferrin, another protein that plays a role in the proper transport of iron within the body. Molecular genetic testing for variants in the SLC40A1 gene is available and necessary to confirm the diagnosis.

Treatment

The treatment of ferroportin disease is directed toward the specific symptoms that are apparent in each individual. Specific treatment may depend on the severity and form of ferroportin disease.

Individuals with the form of ferroportin disease that resembles classic hemochromatosis may be treated with regular phlebotomy, a procedure in which blood is removed via a vein. Individuals with the mild form of ferroportin disease may not necessarily require treatment and phlebotomy in these individuals is often complicated by anemia.

Genetic counseling is recommended for affected individuals and their families. Other treatment is symptomatic and supportive.

TYPE OF DOCTOR AND DEPARTMENT: Gastroenterology and Hepatology SPECIALIST CAN DIAGNOSE THIS DISEASE. 

Comments

Post a Comment

Popular posts from this blog

Charge Syndrome

Overview CHARGE syndrome is a recognizable genetic syndrome with known pattern of features. It is an extremely complex syndrome, involving extensive medical and physical difficulties that differ from child to child. CHARGE syndrome is correlated with genetic mutation to CHD7 and the prevalence of CHARGE syndrome is 1:10,000-1:15,000 live births. Babies with CHARGE syndrome are often born with life-threatening birth defects. They spend many months in the hospital and undergo many surgeries and other treatments. Swallowing and breathing problems make life difficult even when they come home. Most have hearing two little girls sitting on a carpet, one girl has a trach and is biting her finger.loss, vision loss, and balance problems that delay their development and communication. Despite these seemingly insurmountable obstacles, children with CHARGE syndrome often far surpass their medical, physical, educational, and social expectations. One of the hidden features of CHARGE syndrome is the ...
7 comments
Read more

Sjogren's syndrome

Sjogren's syndrome Overview Sjogren's (SHOW-grins) syndrome is a disorder of your immune system identified by its two most common symptoms — dry eyes and a dry mouth. The condition often accompanies other immune system disorders, such as rheumatoid arthritis and lupus. In Sjogren's syndrome, the mucous membranes and moisture-secreting glands of your eyes and mouth are usually affected first — resulting in decreased tears and saliva. Although you can develop Sjogren's syndrome at any age, most people are older than 40 at the time of diagnosis. The condition is much more common in women. Treatment focuses on relieving symptoms. Symptoms The two main symptoms of Sjogren's syndrome are: Dry eyes . Your eyes might burn, itch or feel gritty — as if there's sand in them. Dry mouth. Your mouth might feel like it's full of cotton, making it difficult to swallow or speak. Some people with Sjogren's syndrome also have one or more of the following: Joint pain, swel...
Post a Comment
Read more

Aarskog syndrome

  Aarskog syndrome is a very rare disease that affects a person's height, muscles, skeleton, genitals, and appearance. It can be passed down through families (inherited). Causes Aarskog syndrome is a genetic disorder that is linked to the X chromosome. It affects mainly males, but females may have a milder form. The condition is caused by changes (mutations) in a gene called "faciogenital dysplasia" (FGD1). Symptoms Symptoms of this condition include: Belly button that sticks out Bulge in the groin or scrotum Delayed sexual maturity Delayed teeth Downward palpebral slant to eyes (palpebral slant is the direction of the slant from the outer to inner corner of the eye) Hairline with a "widow's peak" Mildly sunken chest Mild to moderate mental problems Mild to moderate short height which may not be obvious until the child is 1 to 3 years old Poorly developed middle section of the face Rounded face Scrotum surrounds the penis (shawl scrotum) Short fingers and to...
Post a Comment
Read more